Loading...
National Health Investors, Inc.
NHI•NYSE
Real Estate
REIT - Healthcare Facilities
$71.10
$-0.04(-0.06%)
National Health Investors, Inc. (NHI) Financial Performance & Income Statement Overview
Review National Health Investors, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.80%
↑ 4.80%
Operating Income Growth
6.02%
↑ 6.02%
Net Income Growth
1.72%
↑ 1.72%
Operating Cash Flow Growth
12.64%
↑ 12.64%
Operating Margin
54.37%
↑ 54.37%
Gross Margin
96.70%
↑ 96.70%
Net Profit Margin
41.17%
↑ 41.17%
ROE
10.72%
↑ 10.72%
ROIC
8.25%
↑ 8.25%
National Health Investors, Inc. (NHI) Income Statement & Financial Overview
Review National Health Investors, Inc.'s (NHI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $85.75M | $82.94M | $85.69M | $82.24M |
| Cost of Revenue | $2.84M | $2.79M | $31.45M | $31.27M |
| Gross Profit | $82.91M | $80.16M | $54.24M | $50.96M |
| Gross Profit Ratio | $0.97 | $0.97 | $0.63 | $0.62 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.83M | $5.05M | $5.04M | $5.88M |
| Operating Expenses | $40.00M | $7.86M | $33.009M | $5.46M |
| Total Costs & Expenses | $42.84M | $7.84M | $36.37M | $36.73M |
| Interest Income | -$1.22M | -$873000.00 | ||
| Interest Expense | $14.03M | $14.07M | ||
| Depreciation & Amortization | $18.68M | $18.49M | $18.21M | $18.23M |
| EBITDA | $75.45M | $65.24M | $67.54M | $63.73M |
| EBITDA Ratio | $0.88 | $0.79 | $0.79 | $0.78 |
| Operating Income | $42.91M | $75.11M | $49.32M | $45.51M |
| Operating Income Ratio | $0.50 | $0.91 | $0.58 | $0.55 |
| Other Income/Expenses (Net) | -$169000.00 | -$46.87M | -$14.37M | -$14.85M |
| Income Before Tax | $42.74M | $28.24M | $34.95M | $30.66M |
| Income Before Tax Ratio | $0.50 | $0.34 | $0.41 | $0.37 |
| Income Tax Expense | -$45000.00 | $0.00 | -$304000.00 | -$290000.00 |
| Net Income | $43.24M | $28.54M | $35.26M | $30.95M |
| Net Income Ratio | $0.50 | $0.34 | $0.41 | $0.38 |
| EPS | $0.96 | $0.66 | $0.81 | $0.71 |
| Diluted EPS | $0.95 | $0.65 | $0.81 | $0.71 |
| Weighted Avg Shares Outstanding | $45.12M | $43.48M | $43.40M | $43.39M |
| Weighted Avg Shares Outstanding (Diluted) | $45.44M | $43.99M | $43.56M | $43.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan